Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laxer, K. D.
Right arrow Articles by Howell, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laxer, K. D.
Right arrow Articles by Howell, B.
NEUROLOGY 1985;35:31
© 1985 American Academy of Neurology

Prolactin changes after seizures classified by EEG monitoring

Kenneth D. Laxer, MD, John P. Mullooly, PhD and Beth Howell, MD

Department of Clinical Neurophysiology (Drs. Laxer and Howell), Good Samaritan Hospital and Medical Center, and The Health Services Research Center (Dr. Mullooly), Kaiser Permanente Medical Care Program, Portland, OR.

We examined the postictal hyperprolactinemia after seizures classified by EEG and video telemetry. Prolactin did rise after complex partial seizures that involved motor behaviors and was not further increased by secondary generalization. Nontemporal partial seizures or pseudoseizures did not demonstrate this increase. There was no difference in prolactin elevation after generalized tonic-clonic seizures, whether secondarily generalized or generalized from onset. A discriminant function accurately classified 94% of patients with pseudoseizures and 66% of patients with true cerebral seizures for an overall classification accuracy of 72%.

Address correspondence and reprint requests to Dr. Laxer, Good Samaritan Hospital and Medical Center, 1015 NW 22nd Avenue, Portland, OR 97210.

Supported in part by a grant from the Epilepsy Association of Oregon.

Accepted for publication April 13, 1984.




This article has been cited by other articles:


Home page
 NeurologyHome page
D. K. Chen, Y. T. So, and R. S. Fisher
Use of serum prolactin in diagnosing epileptic seizures: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, September 13, 2005; 65(5): 668 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
S Ahmad and M W Beckett
Value of serum prolactin in the management of syncope
Emerg. Med. J., March 1, 2004; 21(2): e3 - 3.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. G. Herzog
Prolactin: Quo Vadis?
Arch Neurol, March 1, 1992; 49(3): 223 - 224.
[Abstract] [PDF]

Home page
 Arch NeurolHome page
H. Meierkord, S. Shorvon, S. Lightman, and M. Trimble
Comparison of the Effects of Frontal and Temporal Lobe Partial Seizures on Prolactin Levels
Arch Neurol, March 1, 1992; 49(3): 225 - 230.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
A. K. Afifi, J. J. Corbett, H. S. Thompson, and K. K. Wells
Seizure-Induced Miosis and Ptosis: Association With Temporal Lobe Magnetic Resonance Imaging Abnormalities
J Child Neurol, April 1, 1990; 5(2): 142 - 146.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1985 by AAN Enterprises, Inc.